How insulting to shareholders who know the 12 wins so far, and the hurdles the Company has overcome , for lightweight naysayers to ignore and judge as if they had any expertise.They couldn’t regurgitate this crap on an exchange, no chatrooms allowed.
As stated, the Company’s cashflow financing provides funding from Cure through ultimately to NASDAQ.
Idiot always fits the moniker as there is funding provided and loans paid back out of growth and future revenues at a mutually agreed upon time. This is a model many digital companies utilize as very shareholder friendly and totally supportive of the Company blueprint. This has taken place since 2017, and are long term investors. These are relationships long developed. See chronology.
All audited and plan described as part of Confidential Cover to SEC in Jan 2018.
Stay in your lane as bashers all do nothing but lie to depress pps and
then spew nonsense with scare tactics.
Shareholders support the way forward and the step by step progress being made. The Company is following its blueprint. Ignore the white noise!
If cognitive impairment, see below. Shareholders know by memory.
Reminder of facts:
1 . Acquisition completed 2012
2. Reaudit (3yrs) required through no fault of DBMM Nov 15,2013.
3. Asher litigation Feb 2014
4. Company completed Reaudit and filed all Amended K’s and Q’s (see EdGAR) seamlessly and chronologically in mid- Sept 2014.
5. Cost of Reaudit $157,300.
6. Mitigating circumstances caused delayed filings starting with 10-K 2015
7. Administrative Proceeding for delayed filings May 16,2017
8. New LTIs cashflow financing Oct 2017 starting with Cure
9. Delayed Filings cured May 31, 2018
10. Settlement with Asher at 50% discount.Their CDs canceled. June 18, 2018.
11. Clearance through sponsoring broker, FINRA, Removal of CE and events below
12. Final Order SEC Dismissal June 2,2023.
13. FORWARD All metrics up , UPLIST to QB then NASDAQ step by step
14. New significant software client in Austin, Texas. Geographic growth in US.
